全文获取类型
收费全文 | 4303篇 |
免费 | 176篇 |
国内免费 | 87篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 85篇 |
妇产科学 | 44篇 |
基础医学 | 422篇 |
口腔科学 | 96篇 |
临床医学 | 199篇 |
内科学 | 677篇 |
皮肤病学 | 42篇 |
神经病学 | 314篇 |
特种医学 | 64篇 |
外国民族医学 | 2篇 |
外科学 | 325篇 |
综合类 | 493篇 |
预防医学 | 305篇 |
眼科学 | 37篇 |
药学 | 976篇 |
中国医学 | 278篇 |
肿瘤学 | 194篇 |
出版年
2023年 | 52篇 |
2022年 | 130篇 |
2021年 | 159篇 |
2020年 | 103篇 |
2019年 | 196篇 |
2018年 | 173篇 |
2017年 | 122篇 |
2016年 | 78篇 |
2015年 | 81篇 |
2014年 | 183篇 |
2013年 | 278篇 |
2012年 | 237篇 |
2011年 | 299篇 |
2010年 | 208篇 |
2009年 | 213篇 |
2008年 | 237篇 |
2007年 | 258篇 |
2006年 | 147篇 |
2005年 | 148篇 |
2004年 | 98篇 |
2003年 | 91篇 |
2002年 | 80篇 |
2001年 | 67篇 |
2000年 | 58篇 |
1999年 | 74篇 |
1998年 | 41篇 |
1997年 | 36篇 |
1996年 | 37篇 |
1995年 | 45篇 |
1994年 | 39篇 |
1993年 | 42篇 |
1992年 | 28篇 |
1991年 | 21篇 |
1990年 | 23篇 |
1989年 | 22篇 |
1988年 | 15篇 |
1987年 | 15篇 |
1986年 | 21篇 |
1985年 | 53篇 |
1984年 | 66篇 |
1983年 | 29篇 |
1982年 | 47篇 |
1981年 | 41篇 |
1980年 | 40篇 |
1979年 | 29篇 |
1978年 | 27篇 |
1977年 | 18篇 |
1976年 | 17篇 |
1975年 | 13篇 |
1974年 | 13篇 |
排序方式: 共有4566条查询结果,搜索用时 31 毫秒
81.
82.
目的探讨GL50分子在活化T细胞表面的表达及其生物学意义。方法分别取不同时相(24-144h)激发型CD3单抗联合CD28单抗活化的T细胞,采用流式细胞术分析T细胞表面GL50分子表达阳性率,RT-PCR法检测T细胞内GL50分子mRNA转录水平;^3H-TdR掺入法分析阻断GL50信号对T细胞增殖的影响。结果激发型CD3单抗联合CD28单抗活化T细胞后24h GL50分子阳性表达率为17.2%,其后逐渐升高至活化120h时达最大阳性率95.7%,并维持至活化144h时基本不变;T细胞活化24—144h均可检测到GL50分子mRNA表达;阻断性GL50分子单抗对活化T细胞增殖具有显著抑制作用。结论GL50分子在活化T细胞表面呈诱导性表达,且可与T细胞表面自身受体结合在免疫应答放大效应中发挥重要作用。 相似文献
83.
84.
85.
Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes 总被引:16,自引:0,他引:16
Glebe D Urban S Knoop EV Cag N Krass P Grün S Bulavaite A Sasnauskas K Gerlich WH 《Gastroenterology》2005,129(1):234-245
BACKGROUND & AIMS: Studies on the early steps in the life cycle of hepatitis B virus have been hampered by the lack of readily available target cells. In this study, we mapped a defined virus attachment site to primary hepatocytes that is essential for infection. METHODS: We used purified virus particles from human carrier plasma as an inoculum and primary cultures of tupaia hepatocytes as susceptible target cells and studied the inhibitory effect of amino-terminally acylated preS1-derived lipopeptides on infection interference. RESULTS: Infectivity of virus could be blocked efficiently in this system by amino-terminally acylated peptides containing amino acids 2-18 from the preS1 domain. The addition of amino acids 28-48 enhanced the inhibitory capacity, whereas amino acids 49-78 did not contribute to inhibition. Myristoylated preS1 peptides 2-48 bound strongly to tupaia hepatocytes but not to nonhepatic cells or rodent hepatocytes and thereby inhibited infection even at concentrations of 1 nmol/L completely. Particles consisting only of the small hepatitis B surface protein-the active component of current hepatitis B vaccines-did not bind at all to tupaia hepatocytes, but the addition of the preS1 domain to the particles allowed binding. CONCLUSIONS: The preS1 sequence 2-48 mediates attachment of the virus to its target cells, whereas the small surface protein seems to be involved in other steps. These findings indicate that the current subunit hepatitis B vaccines may be improved by the addition of distinct preS1 epitopes. Moreover, preS1 lipopeptides are promising candidates for specific antiviral therapy against hepatitis B infections. 相似文献
86.
Arterial pulse wave velocities, pulse wave contours, and systolic time intervals were recorded in thirty-nine diabetic children and were compared with recordings taken in twenty-seven normal children. Systolic time intervals were similar in the two groups of subjects. However, brachial and aortic pulse wave velocities were significantly greater in the diabetic than in the normal children (p < 0.025 and < 0.005, respectively). Also, in the diabetic children the time interval from the incisura to the midpoint of the dicrotic wave (I-D) was significantly shortened in both the brachial (p < 0.005) and carotid (p < 0.05) pulse waves as compared to the normal children. These changes in pulse wave velocity and contour are associated with increased wall stiffness that occurs with aging and suggest that the large arteries of diabetic children may exhibit acceleration of the aging process. The severity of these changes bore no direct correlation with the degree of carbohydrate intolerance as judged by insulin requirement. 相似文献
87.
Stefan M. Brudzynski 《Current Neuropharmacology》2015,13(2):180-192
Pharmacological studies of emotional arousal and initiation of emotional states in rats
measured by their ultrasonic vocalizations are reviewed. It is postulated that emission of
vocalizations is an inseparable feature of emotional states and it evolved from mother-infant
interaction. Positive emotional states are associated with emission of 50 kHz vocalizations that could
be induced by rewarding situations and dopaminergic activation of the nucleus accumbens and are
mediated by D1, D2, and partially D3 dopamine receptors. Three biologically significant subtypes of
50 kHz vocalizations have been identified, all expressing positive emotional states: (1) flat calls
without frequency modulation that serve as contact calls during social interactions; (2) frequencymodulated
calls without trills that signal rewarding and significantly motivated situation; and (3) frequency-modulated
calls with trills or trills themselves that are emitted in highly emotional situations associated with intensive affective state.
Negative emotional states are associated with emission of 22 kHz vocalizations that could be induced by aversive
situations, muscarinic cholinergic activation of limbic areas of medial diencephalon and forebrain, and are mediated by
M2 muscarinic receptors. Two biologically significant subtypes of 22 kHz vocalizations have been identified, both
expressing negative emotional sates: (1) long calls that serve as alarm calls and signal external danger; and (2) short calls
that express a state of discomfort without external danger. The positive and negative states with emission of vocalizations
are initiated by two ascending reticular activating subsystems: the mesolimbic dopaminergic subsystem as a specific
positive arousal system, and the mesolimbic cholinergic subsystem as a specific negative arousal system. 相似文献
88.
STUDY OBJECTIVES: Despite the success of specialist cough clinics, there is increasing recognition of a subgroup of chronic coughers in whom a diagnosis cannot be made even after thorough, systematic investigation. We call this condition chronic idiopathic cough (CIC). The aim of this study is to compare the clinical characteristics of CIC patients with those of coughers in whom a diagnosis has been established (non-CIC) to see if there is a recognizable clinical pattern that distinguishes CIC from non-CIC. DESIGN: Retrospective analysis of the medical records of chronic cough patients. SETTING: The Royal Brompton Hospital Chronic Cough Clinic, London. PATIENTS: One hundred patients with chronic cough referred to the Royal Brompton Hospital Cough Clinic between October 2000 and February 2004. RESULTS: Seventy-one percent of all patients were female. Median age was 57 years (range, 19 to 81 years), with a median duration of symptoms of 48 months (range, 2 to 384 months). The primary diagnoses were CIC (42%), postnasal drip syndromes (22%), gastroesophageal reflux disease (16%), asthma (7%), and others (13%). In CIC patients, the median age at referral, age at onset of cough, and proportion of females did not differ significantly from non-CIC patients. CIC patients had a longer median duration of cough (72 months vs 24 months, p = 0.002), were more likely to report an upper respiratory tract infection (URTI) as the initial trigger of their cough (48% vs 24%, p = 0.0014), and had a significantly lower cough threshold in response to capsaicin (log concentration of capsaicin required to induce five or more coughs, - 0.009 vs 0.592, p = 0.032) than non-CIC patients. CONCLUSIONS: Patients with CIC commonly describe a URTI that initiates their cough, which then lasts for many years, and they demonstrate an exquisitely sensitive cough reflex. We believe that CIC may be a distinct clinical entity with an as-yet unidentified underlying pathology. 相似文献
89.
Hideyuki Ikematsu Naoki Kawai Norio Iwaki Seizaburo Kashiwagi Yusuke Ishikawa Hiroki Yamaguchi Kazuhito Shiosakai 《Journal of infection and chemotherapy》2018,24(9):707-712
To assess the extent of susceptibility to the four most commonly used neuraminidase inhibitors (NAIs) in the viruses epidemic in the 2016–17 Japanese influenza season, we measured the 50% inhibitory concentration (IC50) of these NAIs for influenza virus isolates from patients and compared them with the results from the 2010–11 to 2015–16 seasons.Viral isolation was done with specimens obtained prior to treatment, and the type and subtype was determined by RT-PCR using type- and subtype-specific primers. The IC50 was determined by a neuraminidase inhibition assay using a fluorescent substrate.A total of 276 virus isolates, 6 A (H1N1)pdm09 (2.2%), 249 A (H3N2) (90.2%), and 21 B (7.6%), had the IC50 measured for the four NAIs. B isolates included 11 (52.4%), 9 (42.9%), and one (4.8%) of the Victoria, Yamagata, and undetermined strains, respectively.No A (H1N1)pdm09 with highly reduced sensitivity for oseltamivir was found in the 2016–17 season. No isolate with highly reduced sensitivity to the four NAIs have been found for A (H3N2) or B from the 2010–11 to 2016–17 seasons. No significant trend of increase or decrease was found in the geometric mean IC50s of the four NAIs during the seven studied seasons.These results indicate that the sensitivity to the four commonly used NAIs has been maintained and that any change in the effectiveness of these NAIs would be minute. Common usage of NAIs for patient treatment has not been a driving force in the selection of NAI resistant viruses. 相似文献
90.
《Vaccine》2015,33(21):2470-2476
Background/objectivesAnthrax vaccine adsorbed (AVA, BioThrax®) is recommended for post-exposure prophylaxis administration for the US population in response to large-scale Bacillus anthracis spore exposure. However, no information exists on AVA use in children and ethical barriers exist to performing pre-event pediatric AVA studies. A Presidential Ethics Commission proposed a potential pathway for such studies utilizing an age de-escalation process comparing safety and immunogenicity data from 18 to 20 year-olds to older adults and if acceptable proceeding to evaluations in younger adolescents. We conducted exploratory summary re-analyses of existing databases from 18 to 20 year-olds (n = 74) compared to adults aged 21 to 29 years (n = 243) who participated in four previous US government funded AVA studies.MethodsData extracted from studies included elicited local injection-site and systemic adverse events (AEs) following AVA doses given subcutaneously at 0, 2, and 4 weeks. Additionally, proportions of subjects with ≥4-fold antibody rises from baseline to post-second and post-third AVA doses (seroresponse) were obtained.ResultsRates of any elicited local AEs were not significantly different between younger and older age groups for local events (79.2% vs. 83.8%, P = 0.120) or systemic events (45.4% vs. 50.5%, P = 0.188). Robust and similar proportions of seroresponses to vaccination were observed in both age groups.ConclusionsAVA was safe and immunogenic in 18 to 20 year-olds compared to 21 to 29 year-olds. These results provide initial information to anthrax and pediatric specialists if AVA studies in adolescents are required. 相似文献